| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
You see it in every major town and city. With 6,600 patient access points, Quest Diagnostics Incorporated (DGX) is one of the leading providers of patient diagnostics, laboratory testing, and genetic testing services in the United States. When you consider the importance of diagnostics in the medical field as well as testing services for a US labor force that faces pressure from drugs, Quest Diagnostics seems like a potentially lucrative investment opportunity.
Heightened awareness of the dangers of prescription opioids has prompted a movement to limit use of opioid therapies for patients with acute or chronic pain. Primary care practitioners stand on the front lines of this care shift, and many are curtailing prescribing opioids in response. But is the solution to the drug epidemic this straightforward? These latest data align with findings of an analysis of drug monitoring laboratory tests performed by Quest Diagnostics and published in the Journal of Addiction Medicine.
Quest Diagnostics Chairman, President, and Chief Executive Officer Steve Rusckowski led a group of dignitaries at a groundbreaking ceremony for a new flagship laboratory at the On3 campus earlier this month. With more than 1,100 employees expected to work at the new 250,000-square-foot facility when it opens in 2021, the lab, on the Clifton side of the ON3 campus redevelopment project, will be the company's largest.
The giant inflatable colon stolen from a Kansas City nonprofit last year will soon have a name. Quest Diagnostics and the Colon Cancer Coalition are hosting a naming ceremony Friday, March 1 at noon. Police said last year, thanks to a tip, officers found it in a vacant house near Virginia Avenue and Gregory Boulevard.
Roughly a year after its launch, a pilot project exploring the use of blockchain to manage healthcare provider records is paying off. The effort, which has thus far focused on some 100,000 provider locations across Texas, has produced substantial efficiencies for participating firms, said Jason O'Meara, senior director of architecture at Quest Diagnostics, one of the seven companies comprising the Synaptic Health Alliance, the healthcare industry group leading the project.